v3.25.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)
Total
Common Stock
Additional Paid-in- Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2023   104,055,168        
Beginning balance at Dec. 31, 2023 $ 305,170,956 $ 10,406 $ 320,693,866 $ (21,394,310) $ 1,484,905 $ 4,376,089
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock repurchased (in shares)   (1,255,614)        
Common stock repurchased (4,877,559) $ (126) (4,877,433)      
Stock-based compensation (in shares)   165,688        
Stock-based compensation 4,340,405 $ 17 4,340,388      
Shares withheld for taxes (in shares)   (3,747)        
Shares withheld for taxes (20,946)   (20,946)      
Net loss attributable to noncontrolling interests (624,070)         (624,070)
Foreign currency translation (140,134)       (140,134)  
Net income attributable to stockholders of DocGo Inc. and Subsidiaries 11,227,449     11,227,449    
Ending balance (in shares) at Mar. 31, 2024   102,961,495        
Ending balance at Mar. 31, 2024 315,076,101 $ 10,297 320,135,875 (10,166,861) 1,344,771 3,752,019
Beginning balance (in shares) at Dec. 31, 2023   104,055,168        
Beginning balance at Dec. 31, 2023 305,170,956 $ 10,406 320,693,866 (21,394,310) 1,484,905 4,376,089
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss attributable to noncontrolling interests (1,295,099)          
Net income attributable to stockholders of DocGo Inc. and Subsidiaries 17,757,052          
Ending balance (in shares) at Jun. 30, 2024   101,682,770        
Ending balance at Jun. 30, 2024 317,986,604 $ 10,168 317,403,960 (3,637,258) 1,378,744 2,830,990
Beginning balance (in shares) at Mar. 31, 2024   102,961,495        
Beginning balance at Mar. 31, 2024 315,076,101 $ 10,297 320,135,875 (10,166,861) 1,344,771 3,752,019
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock repurchased (in shares)   (1,395,957)        
Common stock repurchased (4,904,452) $ (140) (4,904,312)      
Stock-based compensation (in shares)   181,136        
Stock-based compensation 2,417,110 $ 18 2,417,092      
Shares withheld for taxes (in shares)   (64,334)        
Shares withheld for taxes (245,386) $ (7) (245,379)      
Exercise of stock options (in shares)   430        
Exercise of stock options 684   684      
Net loss attributable to noncontrolling interests (671,029)         (671,029)
Dividends paid to noncontrolling interest (250,000)         (250,000)
Foreign currency translation 33,973       33,973  
Net income attributable to stockholders of DocGo Inc. and Subsidiaries 6,529,603     6,529,603    
Ending balance (in shares) at Jun. 30, 2024   101,682,770        
Ending balance at Jun. 30, 2024 $ 317,986,604 $ 10,168 317,403,960 (3,637,258) 1,378,744 2,830,990
Beginning balance (in shares) at Dec. 31, 2024 101,910,883 101,910,883        
Beginning balance at Dec. 31, 2024 $ 315,179,130 $ 10,191 321,087,583 (1,402,167) 1,221,869 (5,738,346)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock repurchased (in shares)   (1,953,169)        
Common stock repurchased (5,751,954) $ (195) (5,751,759)      
Stock-based compensation (in shares)   391,777        
Stock-based compensation 4,282,366 $ 39 4,282,327      
Shares withheld for taxes (in shares)   (165,603)        
Shares withheld for taxes (1,200,977) $ (17) (1,200,960)      
Net loss attributable to noncontrolling interests (1,673,985)         (1,673,985)
Other comprehensive income 495,538       495,538  
Net income attributable to stockholders of DocGo Inc. and Subsidiaries (9,405,315)     (9,405,315)    
Ending balance (in shares) at Mar. 31, 2025   100,183,888        
Ending balance at Mar. 31, 2025 $ 301,924,803 $ 10,018 318,417,191 (10,807,482) 1,717,407 (7,412,331)
Beginning balance (in shares) at Dec. 31, 2024 101,910,883 101,910,883        
Beginning balance at Dec. 31, 2024 $ 315,179,130 $ 10,191 321,087,583 (1,402,167) 1,221,869 (5,738,346)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (in shares) 0          
Net loss attributable to noncontrolling interests $ (3,808,632)          
Net income attributable to stockholders of DocGo Inc. and Subsidiaries $ (20,560,561)          
Ending balance (in shares) at Jun. 30, 2025 97,757,075 97,757,075        
Ending balance at Jun. 30, 2025 $ 287,730,732 $ 9,776 316,509,060 (21,962,728) 2,721,602 (9,546,978)
Beginning balance (in shares) at Mar. 31, 2025   100,183,888        
Beginning balance at Mar. 31, 2025 301,924,803 $ 10,018 318,417,191 (10,807,482) 1,717,407 (7,412,331)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock repurchased (in shares)   (2,527,900)        
Common stock repurchased (5,076,952) $ (253) (5,076,699)      
Stock-based compensation (in shares)   166,042        
Stock-based compensation 3,308,154 $ 17 3,308,137      
Shares withheld for taxes (in shares)   (64,955)        
Shares withheld for taxes (139,575) $ (6) (139,569)      
Net loss attributable to noncontrolling interests (2,134,647)         (2,134,647)
Other comprehensive income 1,004,195       1,004,195  
Net income attributable to stockholders of DocGo Inc. and Subsidiaries $ (11,155,246)     (11,155,246)    
Ending balance (in shares) at Jun. 30, 2025 97,757,075 97,757,075        
Ending balance at Jun. 30, 2025 $ 287,730,732 $ 9,776 $ 316,509,060 $ (21,962,728) $ 2,721,602 $ (9,546,978)